SEI Investments
ICPT

SEI Investments’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

SEI Investments’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-11,358
Closed -$126K – 2727
2023
Q2 		$126K Sell
11,358
-23,239
-67% -$324K ﹤0.01% 2535
2023
Q1 		$465K Sell
34,597
-8,216
-19% -$142K ﹤0.01% 2156
2022
Q4 		$530K Buy
+42,813
New +$606K ﹤0.01% 1985
2020
Q4 		– Sell
-67,609
Closed -$2.77M – 2554
2020
Q3 		$2.77M Sell
67,609
-8,498
-11% -$390K 0.01% 1141
2020
Q2 		$3.61M Buy
76,107
+71,287
+1,479% +$5.51M 0.01% 998
2020
Q1 		$279K Sell
4,820
-4,780
-50% -$430K ﹤0.01% 1974
2019
Q4 		$1.19M Buy
9,600
+903
+10% +$80.8K ﹤0.01% 1573
2019
Q3 		$552K Buy
8,697
+2,192
+34% +$147K ﹤0.01% 1832
2019
Q2 		$497K Buy
6,505
+3,000
+86% +$269K ﹤0.01% 1882
2019
Q1 		$370K Buy
3,505
+3,031
+639% +$331K ﹤0.01% 2036
2018
Q4 		$40K Buy
474
+308
+186% +$31.9K ﹤0.01% 2392
2018
Q3 		$20K Sell
166
-580
-78% -$61.4K ﹤0.01% 2382
2018
Q2 		$63K Buy
746
+72
+11% +$5.27K ﹤0.01% 2433
2018
Q1 		$41K Buy
674
+91
+16% +$5.48K ﹤0.01% 2422
2017
Q4 		$34K Sell
583
-85
-13% -$5.36K ﹤0.01% 2458
2017
Q3 		$39K Sell
668
-15
-2% -$1.62K ﹤0.01% 2332
2017
Q2 		$83K Buy
683
+380
+125% +$44K ﹤0.01% 2112
2017
Q1 		$34K Buy
303
+197
+186% +$23K ﹤0.01% 2225
2016
Q4 		$12K Buy
106
+13
+14% +$1.55K ﹤0.01% 2443
2016
Q3 		$16K Buy
93
+47
+102% +$7.41K ﹤0.01% 2317
2016
Q2 		$6K Buy
46
+22
+92% +$3.21K ﹤0.01% 2367
2016
Q1 		$3K Sell
24
-235
-91% -$27.7K ﹤0.01% 2343
2015
Q4 		$38K Sell
259
-1,988
-88% -$337K ﹤0.01% 1968
2015
Q3 		$372K Sell
2,247
-1,413
-39% -$311K ﹤0.01% 1396
2015
Q2 		$883K Sell
3,660
-4,468
-55% -$1.19M 0.01% 1016
2015
Q1 		$2.29M Buy
8,128
+3,885
+92% +$841K 0.02% 698
2014
Q4 		$662K Buy
+4,243
New +$784K 0.01% 1063

Other funds holding ICPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

SEI Investments's ICPT Position: Q3 2023 in Review

SEI Investments sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2023, closing a stake of 11,358 shares — an estimated $126K sold.

SEI Investments first reported a position in ICPT in Q4 2014 and held it in 27 quarters. The position peaked at $3.61M in Q2 2020. 146 funds tracked by Wall St. Rank hold ICPT as of Q3 2023.

  • SEI Investments reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
  • SEI Investments sold 11,358 Intercept Pharmaceuticals, Inc. shares in Q3 2023, an estimated $126K.
  • SEI Investments first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2014 and held it in 27 quarters.
  • SEI Investments's Intercept Pharmaceuticals, Inc. position peaked at $3.61M in Q2 2020.
  • 146 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2023.

Based on SEI Investments's 13F filing for Q3 2023, filed 14 Nov 2023.